Additional file 2 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
| Creators |
|
|---|---|
| Contributors | |
| Publication date | 2020 |
| Description | Additional file 2. Molecular subtypes. Overview of the molecular subtype frequency as determined by immunohistochemistry of ER and HER2 and as predicted by the SCMOD2 model (R package genefu) using TGCA BRCA primary tumour gene expression data. Subtypes are listed for the 1095 patients for whom gene expression data is available (Fig. 1). |
| Publisher | Figshare |
| Organisations |
|
| Document type | Dataset |
| Related publication | Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer |
| DOI | https://doi.org/10.6084/m9.figshare.12673815.v1 |
| Other links | https://springernature.figshare.com/articles/Additional_file_2_of_Candidate_methylation_sites_associated_with_endocrine_therapy_resistance_in_ER_HER2-_breast_cancer/12673815/1 |
| Permalink to this page | |